LFMD Quote, Financials, Valuation and Earnings

Eli Lilly & Co. has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of 31.72%. LifeMD, Inc.'s return on equity of -- beat Eli Lilly & Co.'s return on equity of 106.26%.

LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 190.88%. On the other hand Eli Lilly & Co. has an analysts' consensus of $1,150.00 which suggests that it could grow by 14.6%. Given that LifeMD, Inc. has higher upside potential than Eli Lilly & Co., analysts believe LifeMD, Inc. is more attractive than Eli Lilly & Co..

LifeMD, Inc. has a beta of 1.898, which suggesting that the stock is 89.773% more volatile than S&P 500. In comparison Eli Lilly & Co. has a beta of 0.388, suggesting its less volatile than the S&P 500 by 61.171%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Eli Lilly & Co. offers a yield of 0.6% to investors and pays a quarterly dividend of $1.50 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. Eli Lilly & Co. pays out 44.39% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeMD, Inc. quarterly revenues are $60.2M, which are smaller than Eli Lilly & Co. quarterly revenues of $17.6B. LifeMD, Inc.'s net income of -$3.6M is lower than Eli Lilly & Co.'s net income of $5.6B. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while Eli Lilly & Co.'s PE ratio is 49.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.56x versus 15.40x for Eli Lilly & Co.. Usually stocks with elevated PS ratios are considered overvalued.

Veradigm, Inc. has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of --. LifeMD, Inc.'s return on equity of -- beat Veradigm, Inc.'s return on equity of --.

LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 190.88%. On the other hand Veradigm, Inc. has an analysts' consensus of $5.83 which suggests that it could grow by 25.45%. Given that LifeMD, Inc. has higher upside potential than Veradigm, Inc., analysts believe LifeMD, Inc. is more attractive than Veradigm, Inc..

LifeMD, Inc. has a beta of 1.898, which suggesting that the stock is 89.773% more volatile than S&P 500. In comparison Veradigm, Inc. has a beta of 0.543, suggesting its less volatile than the S&P 500 by 45.708%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veradigm, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. Veradigm, Inc. pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeMD, Inc. quarterly revenues are $60.2M, which are larger than Veradigm, Inc. quarterly revenues of --. LifeMD, Inc.'s net income of -$3.6M is higher than Veradigm, Inc.'s net income of --. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while Veradigm, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.56x versus 0.86x for Veradigm, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Streamline Health Solutions, has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of -34.2%. LifeMD, Inc.'s return on equity of -- beat Streamline Health Solutions,'s return on equity of -64.34%.

LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 190.88%. On the other hand Streamline Health Solutions, has an analysts' consensus of $22.50 which suggests that it could fall by -71.91%. Given that LifeMD, Inc. has higher upside potential than Streamline Health Solutions,, analysts believe LifeMD, Inc. is more attractive than Streamline Health Solutions,.

LifeMD, Inc. has a beta of 1.898, which suggesting that the stock is 89.773% more volatile than S&P 500. In comparison Streamline Health Solutions, has a beta of 2.070, suggesting its more volatile than the S&P 500 by 106.993%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Streamline Health Solutions, offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. Streamline Health Solutions, pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeMD, Inc. quarterly revenues are $60.2M, which are larger than Streamline Health Solutions, quarterly revenues of $4.8M. LifeMD, Inc.'s net income of -$3.6M is lower than Streamline Health Solutions,'s net income of -$1.6M. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while Streamline Health Solutions,'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.56x versus 1.18x for Streamline Health Solutions,. Usually stocks with elevated PS ratios are considered overvalued.

TruBridge, Inc. has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of 6.3%. LifeMD, Inc.'s return on equity of -- beat TruBridge, Inc.'s return on equity of 1.61%.

LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 190.88%. On the other hand TruBridge, Inc. has an analysts' consensus of $22.60 which suggests that it could grow by 7.68%. Given that LifeMD, Inc. has higher upside potential than TruBridge, Inc., analysts believe LifeMD, Inc. is more attractive than TruBridge, Inc..

LifeMD, Inc. has a beta of 1.898, which suggesting that the stock is 89.773% more volatile than S&P 500. In comparison TruBridge, Inc. has a beta of 0.637, suggesting its less volatile than the S&P 500 by 36.325%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TruBridge, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. TruBridge, Inc. pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeMD, Inc. quarterly revenues are $60.2M, which are smaller than TruBridge, Inc. quarterly revenues of $86.1M. LifeMD, Inc.'s net income of -$3.6M is lower than TruBridge, Inc.'s net income of $5.4M. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while TruBridge, Inc.'s PE ratio is 112.93x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.56x versus 0.88x for TruBridge, Inc.. Usually stocks with elevated PS ratios are considered overvalued.